L'ORÉAL: News Release: "L'Oréal signs agreement with Valeant to acquire CeraVe and two other brands"


10.01.17 08:35
Meldung
 
<strong>L'Oréal</strong>: News Release: "L'Oréal signs agreement with Valeant to acquire CeraVe and two other brands"

L'ORÉAL SIGNS AGREEMENT WITH VALEANT TO ACQUIRE

CERAVE AND TWO OTHER BRANDS

           

Clichy, New York - 10 January 2017 - L'Oréal announced today the signing of a definitive agreement with Valeant to acquire the skincare brands CeraVe, AcneFree and Ambi for a cash purchase price of 1.3 billion US dollars.

CeraVe was founded in 2005 and offers a range of advanced skincare products, specifically cleansers, moisturizers, sunscreens, healing ointments and a dedicated baby line. Developed with dermatologists, CeraVe is one of the fastest growing skincare brands in the U.S. with average growth over the past two years exceeding 20%. CeraVe's multi-channel distribution strategy includes drug stores, mass and beauty retailers, and select online outlets.

AcneFree markets and distributes a full range of OTC cleansers and acne treatments in the U.S., Ambi distributes skincare products formulated for the needs of multicultural consumers. Both brands are distributed in drug stores, mass retailers and select online outlets.

The three brands have annualized combined revenue of approximately 168 million US dollars.

"The acquisition of CeraVe, AcneFree and Ambi strongly complement L'Oréal's brand portfolio," said Frédéric Rozé, President and CEO of L'Oréal USA. "These three brands, built on strong relationships with health professionals and widely distributed, will nearly double the revenue of our Active Cosmetics Division in the US and will help us satisfy the growing demand for active skincare at accessible prices."

CeraVe, AcneFree and Ambi will become part of L'Oréal's Active Cosmetics Division, which includes brands such as La Roche-Posay, Vichy and SkinCeuticals that are developed with and endorsed by health professionals - dermatologists, pediatricians and other physicians.

"We are thrilled to add CeraVe, AcneFree and Ambi to L'Oréal's Active Cosmetics Division. These brands will deepen our relationships with health professionals and will strengthen our positions in North America in this key and fast growing market. Furthermore, we believe CeraVe has a great potential for international growth in the years to come" said Brigitte Liberman, President of L'Oréal Active Cosmetics Division.

                                                                                                                                                           

The closing is subject to the standard regulatory approvals and other customary conditions.

About L'Oréal

L'Oréal has devoted itself to beauty for over 105 years. With its unique international portfolio of 32 diverse and complementary brands, the Group generated sales amounting to 25.26 billion euros in 2015 and employs 82,900 people worldwide. As the world's leading beauty company, L'Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce. Research and innovation, and a dedicated research team of 3,870 people, are at the core of L'Oréal's strategy, working to meet beauty aspirations all over the world. L'Oréal's sustainability commitment for 2020 "Sharing Beauty With All" sets out ambitious sustainable development objectives across the Group's value chain. www.loreal.com


"This news release does not constitute an offer to sell, or a solicitation of an offer to buy L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our Internet site www.loreal-finance.com.

This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."

Contacts at L'Oréal (switchboard: +33 1 47 56 70 00)

Individual shareholders and market authorities

Mr Jean Régis CAROF

Tel: +33 1 47 56 83 02

jean-regis.carof@loreal.com 

Financial Analysts and Institutional investors

Mrs Françoise LAUVIN

Tel: +33 1 47 56 86 82

francoise.lauvin@loreal.com

Journalists 

Mrs Anne-Laure RICHARD

Tel: +33 1 47 56 80 68

annelaure.richard@loreal.com

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the Internet site for shareholders and investors, www.loreal-finance.com or the L'Oréal Finance app, alternatively, call +33 1 40 14 80 50.


www.loreal.com- Follow us on Twitter @Loreal

 


Read the News Release of 10 January 2017






This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: L'ORÉAL via Globenewswire




 

Breaking News


Kurs- und weitere Informationen zum Thema:

L'Oréal

Aktuelle Diskussionen zum Thema:

L Oreal (WKN: 853888) (09.02.17)
der Konsum bleibt das Problem (10.02.11)

Aktuelle Nachrichten zum Unternehmen:

L'Oréal-Aktie: Q1-Konzernumsatz d. (27.04.17)
L'Oréal-Aktie: Starke Umsatzentwic. (19.04.17)
L'Oréal-Aktie: Erwartungen in Q1 . (19.04.17)
L'Oreal profitiert im ersten Quarta. (18.04.17)
L'Oréal-Aktie: Solides Zahlenwerk . (14.02.17)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

L'Oréal
Weitere Meldungen
 
12.01 Weifa ASA: New license a.
12.01 Wolters Kluwer NV: Share .
12.01 Norsk Hydro: LoI and MoU f.
12.01 Sodexo: Q1 Fiscal 2017 imp.
11.01 Ad hoc: Solvesta AG: Solve.
11.01 MPLX LP to announce 2016.
11.01 Marathon Petroleum Corporat.
11.01 Medigene AG: Veröffentlichu.
11.01 XPO Logistics Awarded Con.
11.01 Ahlstrom: Decisions taken b.
11.01 ETHAN ALLEN PROVIDES.
11.01 Decisions taken by Ahlstrom.
11.01 Elanders AB: Press and An.
11.01 ABN AMRO Press Release:.
11.01 SDRL - Changes to the Boa.
10.01 Ad hoc: Porsche Automobil .
10.01 Ad hoc: VOLKSWAGEN A.
10.01 Ad hoc: VERIANOS Real E.
10.01 Ad hoc: LOTTO24 AG: Seh.
10.01 Fiasp® (fast-acting insulin a.
10.01 Ahlstrom announces positive.
10.01 Ad hoc: HumanOptics AG e.
10.01 Talvivaara Mining Company .
10.01 The court of arbitration dism.
10.01 L'ORÉAL: News Release: "L.
10.01 EQS-Adhoc: ACRON HELVE.
09.01 EVS Broadcast Equipment: .
09.01 Agfa-Gevaert : Classic Fund.
09.01 EQS-Adhoc: LifeWatch AG:.
09.01 Ad hoc: MAX 21 AG führt.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 22371 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
Commerzbank: Kasse klingelt!
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
Den Euro retten, ...
Volker Gelfarth, (29.04.17)
Experte: Volker Gelfarth,
Freenet AG: Die Analyse!
Robert Sasse, (29.04.17)
Experte: Robert Sasse,
Devin Sage TXA Trading ...
Devin Sage, Technische-X-Analyse.de (29.04.17)
Experte: Devin Sage, Technische-X-Analyse.de
Sell in May – oder: Sold by ...
Bernd Niquet, Autor (29.04.17)
Experte: Bernd Niquet, Autor
All- Time-Highs und die ...
Markus Fugmann, actior AG (29.04.17)
Experte: Markus Fugmann, actior AG
K+S-Anleihe im Fokus der ...
Sabine Traub, Börse Stuttgart AG (29.04.17)
Experte: Sabine Traub, Börse Stuttgart AG
Teure und günstige(re) ...
Sven Weisenhaus, Stockstreet GmbH (29.04.17)
Experte: Sven Weisenhaus, Stockstreet GmbH
Sparer – hier gibt es noch ...
Feingold-Research, (29.04.17)
Experte: Feingold-Research,
Anleihen: Politik gibt den ...
Redaktion boerse-frankf., Deutsche Börse AG (29.04.17)
Experte: Redaktion boerse-frankfurt.de, Deutsche Börse AG
Die erwartete ...
Claus Vogt, (29.04.17)
Experte: Claus Vogt,
Den Mutigen gehört die ...
Robert Schröder, Elliott-Waves.com (28.04.17)
Experte: Robert Schröder, Elliott-Waves.com
S&P-500-Index: Ausblick
Christian Zoller, www.boerse-daily.de (28.04.17)
Experte: Christian Zoller, www.boerse-daily.de
Niquet's World
Neues vom Portal
 
Der CFD-Handel - verschiedene Handelszeiten für hohe Renditen
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen